Elevance Health
ELV
434.52
+20.77
+5.02%
Elevance Health
US · ELV
#242 by market cap
Listed 1970
434.52
+20.77
+5.02%
Live - 5344 symbols - heartbeat 233s ago
· 2026-11-04 14:40
✦ Quant Ownership Signal how this is computed
Accumulating
- The number of reporting institutions increased by 17 in the most recent period (2026/Q3).
- Total institutional ownership rose 0.1 percentage points.
Institutional ownership
- Held by institutions
- 95.72% +0.12pp
- Institutions
- 1,935 +17
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund81.55%
Public Company3.33%
Hedge Fund3.32%
Government Pension Fund2.30%
Private Company2.19%
Sovereign Wealth Fund1.93%
Insurance Company0.49%
Family Office/Trust0.15%
VC/PE Fund0.14%
Individual/Insider0.12%
Other4.61%
Top holders as of 2026-06-30
BlackRock
8.79% · 18.99M sh
Vanguard Capital Management, LLC
7.06% · 15.25M sh
State Street Global Advisors
4.83% · 10.43M sh
Wellington Management Group
4.26% · 9.21M sh
Vanguard Portfolio Management, LLC
2.88% · 6.21M sh
Other
72.29%
Sanders Capital, LLC
2.70% · 5.83M sh
Geode Capital Management, LLC
2.39% · 5.17M sh
Harris Associates L.P.
2.28% · 4.92M sh
Artisan Partners Limited Partnership
2.12% · 4.58M sh
First Eagle Investment Management, LLC
1.94% · 4.19M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 31 buys · 19 sells
| Name | Role | Stake |
|---|---|---|
| Gail Boudreaux | Chief Executive Officer | 0.07% |
| Felicia Norwood | Executive VP & Chief Health Benefits Officer | 0.01% |
| Peter Haytaian | Advisor | 0.01% |
| Mark Kaye | Chief Financial Officer | 0.00% |
| Blair Todt | EVP, Chief Legal & Administrative Officer and Interim Head of HR, Global Security & Safety Team | 0.00% |
| Ramiro Peru | Independent Chairperson | 0.00% |
| Erin Wessling | Chief Legal Officer | 0.00% |
| Robert Dixon | Independent Director | 0.00% |
| Charles Kendrick | EVP and President of Commercial & Specialty Health Benefits | 0.00% |
| Ryan Schneider | Independent Director | 0.00% |
| Steven Collis | Independent Director | 0.00% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-21 | Mark Kaye | Chief Financial Officer | Open Market Disposition | -10,584 | $434.00–447.19 |
| 2026-10-01 | Mark Kaye | Chief Financial Officer | Sale to Issuer | -4,161 | $386.43 |
| 2026-10-01 | Mark Kaye | Chief Financial Officer | Other Acquisition | +2,627 | -- |
| 2026-09-02 | Erin Wessling | Chief Legal Officer | Sale to Issuer | -349 | $405.84–414.78 |
| 2026-09-01 | Ryan Craig | Executive Vice President | Sale to Issuer | -144 | $405.84 |
| 2026-07-16 | Ramiro Peru | Independent Chairperson | Open Market Acquisition | +1,000 | $366.05 |
| 2026-07-16 | Gail Boudreaux | Chief Executive Officer | Open Market Acquisition | +2,725 | $366.41–368.25 |
| 2026-07-06 | Ronal Clark | Former Independent Director | Intent to Sell (Form 144) | -1,500 | $419.91 |
| 2026-06-11 | Ronald Penczek | Chief Accounting Officer | Open Market Disposition | -369 | $403.16 |
| 2026-06-10 | Robert Dixon | Independent Director | Open Market Disposition | -151 | $401.77 |
| 2026-05-18 | Ronald Penczek | Chief Accounting Officer | Derivative Exercise and Sale | -1,531 | $271.27–403.13 |
| 2026-05-12 | Ramiro Peru | Independent Chairperson | Other Acquisition | +563 | -- |
| 2026-05-12 | Lewis Hay | Independent Director | Other Acquisition | +563 | -- |
| 2026-05-12 | Steven Collis | Independent Director | Other Acquisition | +563 | -- |
| 2026-05-12 | Deanna Strable-Soethout | Independent Director | Other Acquisition | +563 | -- |
| 2026-05-12 | Amy W. Schulman | Independent Director | Other Acquisition | +563 | -- |
| 2026-05-12 | Bahija Jallal | Independent Director | Other Acquisition | +563 | -- |
| 2026-05-12 | Susan DeVore | Independent Director | Other Acquisition | +563 | -- |
| 2026-05-12 | Ryan Schneider | Independent Director | Other Acquisition | +563 | -- |
| 2026-05-12 | Robert Dixon | Independent Director | Other Acquisition | +563 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-04 14:40:02 · For reference only, not investment advice and not tailored to your situation.
Elevance Health discussion 0 comments